Pierre van der Bruggen

Pierre van der Bruggen

Université Catholique de Louvain

H-index: 72

Europe-Belgium

About Pierre van der Bruggen

Pierre van der Bruggen, With an exceptional h-index of 72 and a recent h-index of 34 (since 2020), a distinguished researcher at Université Catholique de Louvain, specializes in the field of cancer immunology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Immunosuppressive low-density neutrophils in the blood of cancer patients display a mature phenotype

HELIOS-expressing human CD8 T cells exhibit limited effector functions

MDSC in mice and men: mechanisms of immunosuppression in cancer

Identification of an immature subset of PMN-MDSC correlated to response to checkpoint inhibitor therapy in patients with metastatic melanoma

A genetic vaccine encoding shared cancer neoantigens to treat tumors with microsatellite instability

Endophilin-A3 and Galectin-8 control the clathrin-independent endocytosis of CD166

Protocol to assess the suppression of T-cell proliferation by human MDSC

Reverse immunology: From peptide sequence to tumor-killing human T-cell clones

Pierre van der Bruggen Information

University

Position

___

Citations(all)

28185

Citations(since 2020)

4897

Cited By

25679

hIndex(all)

72

hIndex(since 2020)

34

i10Index(all)

158

i10Index(since 2020)

78

Email

University Profile Page

Université Catholique de Louvain

Google Scholar

View Google Scholar Profile

Pierre van der Bruggen Skills & Research Interests

cancer immunology

Top articles of Pierre van der Bruggen

Title

Journal

Author(s)

Publication Date

Immunosuppressive low-density neutrophils in the blood of cancer patients display a mature phenotype

Life Science Alliance

Christophe Vanhaver

Frank Aboubakar Nana

Nicolas Delhez

Mathieu Luyckx

Thibault Hirsch

...

2024/1/1

HELIOS-expressing human CD8 T cells exhibit limited effector functions

Frontiers in Immunology

Damien Neyens

Thibault Hirsch

Achraqat Abdel Aziz Issa Abdel Hadi

Nicolas Dauguet

Christophe Vanhaver

...

2023/12/22

MDSC in mice and men: mechanisms of immunosuppression in cancer

Christophe Vanhaver

Pierre van der Bruggen

Annika M Bruger

2021/6/28

Identification of an immature subset of PMN-MDSC correlated to response to checkpoint inhibitor therapy in patients with metastatic melanoma

Cancers

Françoise Gondois-Rey

Magali Paul

Florence Alcaraz

Sarah Bourass

Jilliana Monnier

...

2021/3/17

A genetic vaccine encoding shared cancer neoantigens to treat tumors with microsatellite instability

Cancer research

Guido Leoni

Anna Morena D'Alise

Gabriella Cotugno

Francesca Langone

Irene Garzia

...

2020/9/15

Endophilin-A3 and Galectin-8 control the clathrin-independent endocytosis of CD166

Nature Communications

Henri-François Renard

François Tyckaert

Cristina Lo Giudice

Thibault Hirsch

Cesar Augusto Valades-Cruz

...

2020/3/19

Protocol to assess the suppression of T-cell proliferation by human MDSC

Annika M Bruger

Christophe Vanhaver

Kirsten Bruderek

Giada Amodio

Ece Tavukçuoğlu

...

2020/1/1

Reverse immunology: From peptide sequence to tumor-killing human T-cell clones

Christophe Vanhaver

Monica Gordon-Alonso

Alexandre Bayard

Maria Teresa Catanese

Didier Colau

...

2020/1/1

See List of Professors in Pierre van der Bruggen University(Université Catholique de Louvain)